CONFIDENTIAL -vi- [*] = Certain information contained in this document, marked by brackets, has been omitted because it is both not material and would be competitively harmful if publicly disclosed. INDEX OF DEFINED TERMS Adverse Event...Joint Commercialization Agreement • February 12th, 2021 • Seagen Inc. • Biological products, (no disgnostic substances) • New York
ContractLetter Agreement • February 12th, 2021 • Seagen Inc. • Biological products, (no disgnostic substances)
* ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED Amendment and without any further action...Seagen Inc. • February 12th, 2021 • Biological products, (no disgnostic substances)
2/30 [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED 1.2 “Analytical Methods” shall mean...Commercial Supply Agreement • February 12th, 2021 • Seagen Inc. • Biological products, (no disgnostic substances)
